作者
Pere Ginès, Laurent Castera, Frank Lammert, Isabel Graupera, Miquel Serra‐Burriel, Alina M Allen, Vincent Wai‐Sun Wong, Phillipp Hartmann, Maja Thiele, Llorenç Caballeria, Robert J de Knegt, Ivica Grgurevic, Salvador Augustin, Emmanuel A Tsochatzis, Jörn M Schattenberg, Indra Neil Guha, Andrea Martini, Rosa M Morillas, Montserrat Garcia‐Retortillo, Harry J de Koning, Núria Fabrellas, Judit Pich, Ann T Ma, M Alba Diaz, Dominique Roulot, Philip N Newsome, Michael Manns, Patrick S Kamath, Aleksander Krag, LiverScreen Consortium Investigators
发表日期
2022/1
来源
Hepatology
卷号
75
期号
1
页码范围
219-228
简介
Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non‐alcoholic fatty liver disease and alcohol‐related liver disease, although chronic hepatitis B and C infections are still major etiological factors in some areas of the world. Recent studies have shown that liver fibrosis can be assessed with relatively high accuracy noninvasively by serological tests, transient elastography, and radiological methods. These modalities may be utilized for screening for liver fibrosis in at‐risk populations. Thus far, a limited number of population‐based studies using noninvasive tests in different areas of the world indicate that a significant percentage of subjects without known liver disease (around 5% in general populations and a higher rate −18% to 27%‐in populations with risk factors for liver disease) have significant …
引用总数